Moreover, marizomib is able to induce apoptosis in MM cells even in the presence of MM growth factors IL-6 and insulin growth factor-1 (IGF-1) and is involved in blocking IL-6 secretion in BMSCs without affecting their viability. Here, IL6 is linked to Miyoshi myopathy.